Investors haven’t had much to complain about marijuana stocks this year, with returns that have generally clawed back all of their losses in 2018 and then some. With an impressive 45% return for the cannabis-concentrated ETFMG Alternative Harvest ETF (NYSEMKT:MJ), it hasn’t taken a ton of stock-picking talent to find winners in the pot space.
Most investors in marijuana have focused on the companies that have generated the most buzz early on, having already seen their market capitalizations jump into the midcap range and boasting high-profile collaborations with well-known companies in other industries. Yet given the success of the cannabis industry, you can expect to hear a lot more from smaller companies in the space throughout 2019 and beyond. Below, we’ll look more closely at Cresco Labs (NASDAQOTH:CRLBF), KushCo (NASDAQOTH:KSHB), and OrganiGram Holdings (NASDAQOTH:OGRMF) have outpaced their larger competitors in the cannabis industry and produced returns that have doubled what the marijuana ETF has given its investors.
|Stock||Market Cap||2019 YTD Return|
|Cresco Labs||$1.75 billion||84%|
|OrganiGram Holdings||$1.09 billion||103%|
Cresco makes a big buy
Cresco is one of many companies that find itself in a strange quandary. The medical cannabis specialist’s shares are listed primarily on the Canadian Securities Exchange, but its headquarters are in Chicago. Cresco offers dry flower, cannabis oil, and other related products, as well as cannabis-infused edibles.